We are live on ! Find out more
LSBPW

LakeShore Biopharma Warrants
LSBPW

Delisted

LSBPW was delisted on the 19th of September, 2025.

Back to rankings

23 hedge funds and large institutions have $501K invested in LakeShore Biopharma Warrants in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $447K → $501K (+$54.2K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.03% less ownership

Funds ownership: 5.33% → 5.3% (-0.03%)

8% less funds holding

Funds holding: 25 → 23 (-2)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
–
Increased
1
Reduced
1
Closed
2
Calls
$105K
Puts
–
Net Calls
+$105K
Net Calls Change
+$43K

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$181

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.12K
2
CAC
Cowen and Company
New York
-$289
3
UBS Group
UBS Group
Switzerland
-$5
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$92.6K – – –
AC
2
Athos Capital
Hong Kong
$84K – – –
VAM
3
Valliance Asset Management
Hong Kong
$66K – – –
Jane Street
4
Jane Street
New York
$43.9K – – –
BP
5
BFAM Partners
Hong Kong
$37.5K – – –
FC
6
Finepoint Capital
Massachusetts
$33.4K – – –
HCM
7
Highbridge Capital Management
New York
$21.4K – – –
BCL
8
Bracebridge Capital LLC
Massachusetts
$20.4K – – –
CAC
9
Cowen and Company
New York
$20.4K -$289 -3,534 -2%
QGA
10
Q Global Advisors
Texas
$11K – – –
WA
11
Whitebox Advisors
Minnesota
$11K – – –
Calamos Advisors
12
Calamos Advisors
Illinois
$9.95K – – –
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$9.25K – – –
Walleye Capital
14
Walleye Capital
New York
$8.79K – – –
CF
15
Cantor Fitzgerald
New York
$6.77K – – –
SCM
16
Shaolin Capital Management
Florida
$6.71K – – –
SCM
17
Saba Capital Management
New York
$5.45K – – –
EAM
18
Exos Asset Management
New York
$4.4K – – –
CS
19
Clear Street
New York
$4.36K +$181 +2,208 +5%
MC
20
Meteora Capital
Florida
$2.2K – – –
SIA
21
SkyView Investment Advisors
New Jersey
$1K – – –
AA
22
Ancora Advisors
Ohio
$444 – – –
HIM
23
HGC Investment Management
Ontario, Canada
$440 – – –
TRCT
24
Tower Research Capital (TRC)
New York
$11 – – –
Citadel Advisors
25
Citadel Advisors
Florida
– -$1.12K -21,918 Closed
1
2

LSBPW Hedge Fund Activity: Q2 2024 in Review

23 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in LakeShore Biopharma Warrants (LSBPW) for Q2 2024, worth a combined $501K — up 12% from $447K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of LSBPW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Clear Street, adding an estimated $181. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.12K sold.

  • 23 institutional investors held LakeShore Biopharma Warrants (LSBPW) as of Q2 2024, down from 25 in Q1 2024.
  • Funds reported $501K of LakeShore Biopharma Warrants stock for Q2 2024, up 12% quarter-over-quarter.
  • 0 funds opened new LakeShore Biopharma Warrants positions in Q2 2024 and 2 closed out, a net change of -2 holders.
  • The largest LakeShore Biopharma Warrants buyer in Q2 2024 was Clear Street, an estimated $181 added.
  • The largest LakeShore Biopharma Warrants seller in Q2 2024 was Citadel Advisors, an estimated $1.12K sold.

Based on aggregated 13F filings for Q2 2024.